[ 3 ] Young NS, Calado RT, Scheinberg P. Current concepts in the pathophysiology and treatment of aplastic anemia[J]. Blood, 2006, 108(8): 2509-2519.
[4]
[ 4 ] Calado RT, Young NS. Telomere maintenance and human bone marrow failure[J]. Blood, 2008, 111(9): 4446-4455.
[5]
Calado RT, Yewdell WT, Wilkerson KL, et al. Sex hormones, acting on the TERT gene, increase telomerase activity in human primary hematopoietic cells[J]. Blood, 2009, 114(11): 2236-2243.
[6]
Vasa-Nicotera M, Brouilette S, Mangino M, et al. Mapping of a major locus that determines telomere length in humans[J]. Am J Hum Genet, 2005, 76(1): 147-151.
[7]
Lee DC, Imm JA, Kim JH, et al. Effect of long-term hormone therapy on telomere length in postmenopausal women[J]. Yonsei Med J, 2005, 46(4): 471-479.
[8]
[ 5 ] Yamaguchi H, Calado RT, Ly H, et al. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia[J]. N Engl J Med, 2005, 352(14): 1413-1424.
[9]
[ 6 ] Frenck RW Jr, Blackburn EH, Shannon KM, et al. The rate of telomere sequence loss in human leukocytes varies with age[J]. Proc Natl Acad Sci USA, 1998, 95(10): 5607？5610．
[10]
[ 7 ] Scheinberg P, Cooper JN, Sloand EM, et al. Association of telomere length of peripheral blood leukocytes with hematopoietic relapse, malignant transformation, and survival in severe aplastic anemia[J]. JAMA, 2010, 304(12): 1358-1364.
[ 9 ] Bayne S, Liu JP. Hormones and growth factors regulate telomerase activity in ageing and cancer[J]. Mol Cell Endocrinol, 2005, 240(1-2): 11-22.
[13]
Kyo S，Takakura M, Kanaya T, et al. Estrogen activates telomerase[J]. Cancer Res, 1999, 59(23)：5917.
[14]
Misiti S, Nanni S, Fontemaggi G, et al. Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells[J]. Mol Cell Biol, 2000, 20(11): 3764-3771.
[15]
Li H, Zhao L, Yang Z, et al. Telomerase is controlled by protein kinase Calpha in human breast cancer cells[J]. J Biol Chem, 1998, 273(50): 33436-33442.
[16]
Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions[J]. Nat Genet, 1998, 19(1): 32-38.
[17]
Mitchell JR, Wood E, Collins K. A telomerase component is defective in the human disease dyskeratosis congenita[J]. Nature, 1999, 402(6761): 551-555.
[18]
Ball SE, Gibson FM, Rizzo S, et al. Progressive telomere shortening in aplastic anemia[J]. Blood, 1998, 91(10): 3582-3592.
[19]
Brummendorf TH, Maciejewski JP, Young NS, et al. Telomere length in leukocyte sub-populations of patients with aplastic anemia[J]. Blood, 2001, 97(4): 895-900.
[20]
Lee JJ, Kook H, Chung IJ, et al. Telomere length changes in patients with aplastic anaemia[J]. Br J Haematol, 2001, 112(4): 1025-1030.
[21]
Du HY, Mason PJ, Bessler M, et al. TINF2 mutations in children with severe aplastic anemia[J]. Pediatr Blood Cancer, 2009, 52(5): 687.
[22]
Yamaguchi H, Baerlocher GM, Lansdorp PL, et al. Mutations of the human telomerase RNA gene (TERC) in aplastic anemiaand myelodysplastic syndrome[J]. Blood, 2003, 102(3): 916-918.
[23]
Fried W, Morley C. Effects of androgenic steroids on erythropoiesis[J]. Steroids, 1985, 46(4-5): 799-826.
[24]
Calado RT, Young NS. Telomere disease[J]. N Engl J Med, 2009, 361(24): 2353-2365.
[25]
Bacigalupo A, Chaple M, Hows J, et al. Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party[J]. Br J Haematol, 1993, 83(1): 145-151.
